Given a urine culture with >100,000 CFU/mL lactose‑fermenting gram‑negative rods identified as Escherichia coli, susceptible to amoxicillin‑clavulanic acid, cefazolin, cefepime, ceftriaxone, ciprofloxacin, levofloxacin, ertapenem, fosfomycin, nitrofurantoin, tobramycin, and trimethoprim‑sulfamethoxazole, but resistant to ampicillin and ESBL‑negative, what is the appropriate oral antibiotic regimen for an uncomplicated urinary tract infection?

Appropriate Oral Antibiotic for Uncomplicated UTI with Susceptible E. coli

For this uncomplicated UTI with fully susceptible E. coli (ESBL-negative), nitrofurantoin 100 mg twice daily for 5 days is the optimal first-line choice, as it provides excellent efficacy while minimizing collateral damage and preserving broader-spectrum agents for more serious infections 1.

Treatment Algorithm

First-Line Options (in order of preference):

1. Nitrofurantoin: 100 mg twice daily for 5 days 1

   • Highest priority due to minimal resistance and collateral damage
   • 97% susceptibility rates in contemporary studies 2
   • Spares systemically active agents for other infections

2. Trimethoprim-sulfamethoxazole (TMP-SMX): 160/800 mg (double-strength) twice daily for 3 days 3

   • Your isolate is susceptible
   • Appropriate when susceptibility is confirmed
   • Should not be used empirically if local resistance >20% 3

3. Fosfomycin: 3 g single dose 3

   • Convenient single-dose therapy
   • May have slightly inferior efficacy compared to other short-course regimens 3

Alternative Options (when first-line cannot be used):

1. Fluoroquinolones (ciprofloxacin 250 mg twice daily or levofloxacin 250 mg daily for 3 days) 3, 4

   • Should be reserved for more serious infections despite susceptibility 3
   • High propensity for collateral damage and ecological impact
   • Not recommended as first-line for simple cystitis even when susceptible 1

2. Beta-lactams (amoxicillin-clavulanate, cefazolin, or cephalexin) for 3-7 days 3

   • Less effective than other options 3
   • More adverse effects compared to other UTI antimicrobials
   • Use only when preferred agents cannot be used 3

Critical Pitfalls to Avoid

• Do NOT use ampicillin alone despite the organism being resistant—it has poor efficacy and high global resistance rates 3

• Avoid fluoroquinolones for uncomplicated cystitis even though your isolate is susceptible—reserve these for pyelonephritis or complicated infections to minimize resistance development 1, 3

• Do NOT use cefepime or ertapenem for simple cystitis—these are parenteral agents reserved for severe infections, pyelonephritis, or hospitalized patients 5

Rationale for Nitrofurantoin Priority

The 2024 WikiGuidelines consensus specifically identifies nitrofurantoin as "a reasonable drug of choice, based on robust evidence of efficacy and its ability to spare use of more systemically active agents" 1. This recommendation is reinforced by:

• Consistently high susceptibility (88-97%) across multiple contemporary studies 6, 2, 7
• Minimal ecological collateral damage
• Excellent urinary concentrations
• 5-day duration with clear evidence base 1

When to Consider Alternatives

Use TMP-SMX (3 days) if:

• Patient has contraindications to nitrofurantoin (CrCl <30 mL/min, pregnancy at term)
• Confirmed susceptibility as in your case
• No recent TMP-SMX exposure in past 3-6 months 3

Use beta-lactams only if:

• Patient cannot tolerate nitrofurantoin or TMP-SMX
• Documented allergy to preferred agents
• Accept that efficacy may be inferior 3

The key principle is antimicrobial stewardship: use the narrowest-spectrum agent that will effectively treat the infection while preserving broader-spectrum antibiotics for resistant organisms and more serious infections 1, 8.